Insider filing · OCX

Patrick W Smith bought $2.2M of Oncocyte (OCX)

Executed Feb 7 2025, disclosed Feb 11 2025, 4 days later.

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

PS Patrick W Smith CHIEF EXECUTIVE OFFICER profile →

Patrick W Smith (CHIEF EXECUTIVE OFFICER) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Axon Enterprise, Inc. (AXON). The largest single filing was $10.0M of AXON (20,000 sh × $500.00, as filed), executed Jun 4.

OCX OCX OCX · 5 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→